Diagnosis and Management of Patients with Suspected Acute Myocardial Infarction

References

• Falk E., Shah P. K., Fuster V. Coronary plaque disruption. Circulation 1995; 92((3))657–71
   PubMed Web of Science ®Google Scholar
• Kim R., Chen E., Lima J., Judd R. Myocardial Gd‐DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. Circulation 1996; 94: 3318–26
   PubMed Web of Science ®Google Scholar
• Lima J. A. Myocardial viability assessment by contrast‐enhanced magnetic resonance imaging. J Am Coll Cardiol 2003; 42((5))902–4
   PubMed Web of Science ®Google Scholar
• Myocardial infarction redefined–a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000; 36((3))959–69
   PubMed Web of Science ®Google Scholar
• Collinson P. O., Stubbs P. J. Are troponins confusing?. Heart 2003; 89: 1285–1287
   PubMed Web of Science ®Google Scholar
• Venge P., Lagerqvist B., Diderholm E., Lindahl B., Wallentin L. Clinical performance of three cardiac troponin assays in patients with unstable coronary artery disease (a FRISC II substudy). Am J Cardiol 2002; 89((9))1035–41
   PubMed Web of Science ®Google Scholar
• Koukkunen H., Penttila K., Kemppainen A., Penttila I., Halinen M. O., Rantanen T. Differences in the diagnosis of myocardial infarction by troponin T compared with clinical and epidemiologic criteria. Am J Cardiol 2001; 88((7))727–31
   PubMed Web of Science ®Google Scholar
• Morrison L. J., Verbeek P. R., Mcdonald A. C., Sawadsky B. V., Cook D. J. Mortality and prehospital thrombolysis for acute myocardial infarction: A meta‐analysis. Jama 2000; 283((20))2686–92
   PubMed Web of Science ®Google Scholar
• Svensson L., Axelsson C., Nordlander R., Herlitz J. Prognostic value of biochemical markers, 12‐lead ECG and patient characteristics amongst patients calling for an ambulance due to a suspected acute coronary syndrome. J Intern Med 2004; 255((4))469–77
   PubMed Web of Science ®Google Scholar
• Ohman E. M., Armstrong P. W., White H. D., Granger C. B., Wilcox R. G., Weaver W. D. Risk stratification with a point‐of‐care cardiac troponin T test in acute myocardial infarction. GUSTOIII Investigators. Global Use of Strategies To Open Occluded Coronary Arteries. Am J Cardiol 1999; 84((11))1281–6
   PubMed Web of Science ®Google Scholar
• Mega J. L., Morrow D. A., De lemos J. A., Sabatine M. S., Murphy S. A., Rifai N. B‐type natriuretic peptide at presentation and prognosis in patients with ST‐segment elevation myocardial infarction: an ENTIRE‐TIMI‐23 substudy. J Am Coll Cardiol 2004; 44((2))335–9
   PubMed Web of Science ®Google Scholar
• Lindahl B., Venge P., Wallentin L. Troponin T identifies patients with unstable coronary artery disease who benefit from long term antithrombotic protection. J Am Coll Cardiol 1997; 29: 43–8
   PubMed Web of Science ®Google Scholar
• Morrow D. A., Antman E. M., Tanasijevic M., Rifai N., De lemos J. A., Mccabe C. H. Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI‐11B substudy. J Am Coll Cardiol 2000; 36((6))1812–7
   PubMed Web of Science ®Google Scholar
• Hamm C. W., Heeschen C., Goldmann B., Vahanian A., Adgey J., Miguel C. M. Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T concentrations. c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators. N Engl J Med 1999; 340((21))1623–9
   PubMed Web of Science ®Google Scholar
• Cannon C., Weintraub W., Demopoulos L., Vicari R., Frey M., Lakkis N. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001; 344: 1879–87
   PubMed Web of Science ®Google Scholar
• Diderholm E., Andren B., Frostfeldt G., Genberg M., Jernberg T., Lagerqvist B. The prognostic and therapeutic implications of increased troponin T concentrations and ST depression in unstable coronary artery disease: the FRISC II invasive troponin T electrocardiogram substudy. Am Heart J 2002; 143((5))760–7
   PubMed Web of Science ®Google Scholar
• Lindmark E., Diderholm E., Wallentin L., Siegbahn A. Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy. JAMA 2001; 286: 2107–13
   PubMed Web of Science ®Google Scholar
• James S., Lindahl B., Lindbäck J., Siegbahn A., Venge P., Armstrong P. Troponin T and N‐terminal pro B‐type Natriuretic peptide predict mortality benefit from coronary revascularization in acute coronary syndromes. Abstract at American Heart Association Scientific session, , et al, 2004
   Google Scholar
• Heeschen C., Dimmeler S., Hamm C. W., Van den brand M. J., Boersma E., Zeiher A. M. Soluble CD40 ligand in acute coronary syndromes. N Engl J Med 2003; 348((12))1104–11
   PubMed Web of Science ®Google Scholar
• Jernberg T., Lindahl B., Siegbahn A., Andren B., Frostfeldt G., Lagerqvist B. N‐terminal pro‐brain natriuretic peptide in relation to inflammation, myocardial necrosis, and the effect of an invasive strategy in unstable coronary artery disease. J Am Coll Cardiol 2003; 42((11))1909–16
   PubMed Web of Science ®Google Scholar
• Morrow D. A., De lemos J. A., Sabatine M. S., Murphy S. A., Demopoulos L. A., Dibattiste P. M. Evaluation of B‐type natriuretic peptide for risk assessment in unstable angina/non‐ST‐elevation myocardial infarction: B‐type natriuretic peptide and prognosis in TACTICS‐TIMI 18. J Am Coll Cardiol 2003; 41((8))1264–72
   PubMed Web of Science ®Google Scholar
• Antman E. M., Cohen M., Bernink P. J., Mccabe C. H., Horacek T., Papuchis G. The TIMI risk score for unstable angina/non‐ST elevation MI: A method for prognostication and therapeutic decision making. Jama 2000; 284((7))835–42
   PubMed Web of Science ®Google Scholar